Advertisement

Trends in Percutaneous Balloon Mitral Valvuloplasty Complications for Mitral Stenosis in the United States (the National Inpatient Sample [2008 to 2018])

Published:September 01, 2022DOI:https://doi.org/10.1016/j.amjcard.2022.07.020
      The epidemiology of mitral stenosis (MS) continues to evolve in the United States. Although the incidence of rheumatic MS has decreased in high-income countries, there is a paucity of data surrounding trends in percutaneous balloon mitral valvuloplasty (PBMV), the current first-line management strategy. This study aimed to identify contemporary trends in PBMV in the United States. Hospitalizations for adults (≥18 years) with MS who underwent PBMV were identified from the National Inpatient Sample from 2008 to 2018. Baseline co-morbidities and outcomes over the study period were determined using Poisson regression. There were 3,980 weighted PBMV cases, 70% of which were women. PBMV hospitalizations decreased from 603 in 2008 to 210 in 2018 (p <0.001). From 2008 to 2018, the age at hospitalization was unchanged in both female and male patients. In contrast, the Charlson Co-morbidity Index increased in both. Baseline heart failure (39% to 64%), hypertension (38% to 43%), and diabetes mellitus (17% to 26%) all substantially increased over the study period. In-hospital mortality occurred in 2% of female and 5% of male patients and was unchanged from 2008 to 2018. Vascular complications (12%) and acute kidney injury (10%) were the most frequent postprocedural complications during the 11-year study period. A composite of mortality or any postprocedural complication did not vary by gender (odds ratio 1.23, 95% confidence interval 0.88 to 1.72). In conclusion, the use of PBMV significantly decreased from 2008 to 2018, and patients with MS who underwent PBMV over this period had an increased burden of co-morbidities, elevated postprocedural complication rate, and no change in in-hospital mortality.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Chandrashekhar Y
        • Westaby S
        • Narula J
        Mitral stenosis.
        Lancet. 2009; 374: 1271-1283
        • Badheka AO
        • Shah N
        • Ghatak A
        • Patel NJ
        • Chothani A
        • Mehta K
        • Singh V
        • Patel N
        • Grover P
        • Deshmukh A
        • Panaich SS
        • Savani T
        • Bhalara V
        • Arora S
        • Rathod A
        • Desai H
        • Kar S
        • Alfonso C
        • Palacios IF
        • Grines C
        • Schreiber T
        • Rihal CS
        • Makkar R
        • Cohen MG
        • O'Neill W
        • de Marchena E.
        Balloon mitral valvuloplasty in the United States: a 13-year perspective.
        Am J Med. 2014; 127 (e1–1126.e12): 1126
        • Nkomo VT
        • Gardin JM
        • Skelton TN
        • Gottdiener JS
        • Scott CG
        • Enriquez-Sarano M.
        Burden of valvular heart diseases: a population-based study.
        Lancet. 2006; 368: 1005-1011
        • Palacios IF.
        Percutaneous mitral balloon valvuloplasty: worldwide trends.
        J Am Heart Assoc. 2019; 8e012898
        • Palacios IF
        • Arzamendi D.
        Percutaneous mitral balloon valvuloplasty for patients with rheumatic mitral stenosis.
        Interv Cardiol Clin. 2012; 1: 45-61
      1. Agency for Healthcare Research and Quality. NIS Trend Weights. Available at: https://www.hcup-us.ahrq.gov/db/nation/nis/trendwghts.jsp. Accessed on January 30, 2021.

      2. Barrett M, Mummert A, Kenney T, Heslin K. Methods applying AHRQ quality indicators to Healthcare Cost and Utilization Project (HCUP) data for the 2018 National Healthcare Quality and Disparities Report (QDR); 2019.

      3. ICD-9-CM: International Classification of Diseases.
        World Health Organization, Ninth Revision, Clinical Modification. Geneva1978
        • ICD-10-CM/PCS
        International Classification of Diseases, Tenth Revision, Clinical Modification/Procedure Coding System.
        World Health Organization, Geneva2016
      4. Agency for Healthcare Research and Quality. Healthcare Cost and Utilization Project (HCUP): overview of the National Inpatient Sample (NIS); 2000 to 2017. Available at: http://www.hcup-us.ahrq.gov/nisoverview.jsp. Accessed on January 30, 2021.

        • Meneguz-Moreno RA
        • Costa JR
        • Gomes NL
        • Braga SLN
        • Ramos AIO
        • Meneghelo Z
        • Maldonado M
        • Ferreira-Neto AN
        • Franca JID
        • Siqueira D
        • Esteves C
        • Sousa A
        • Sousa JE
        • Abizaid A.
        Very long term follow-up after percutaneous balloon mitral valvuloplasty.
        JACC Cardiovasc Interv. 2018; 11: 1945-1952
        • Quan H
        • Sundararajan V
        • Halfon P
        • Fong A
        • Burnand B
        • Luthi JC
        • Saunders LD
        • Beck CA
        • Feasby TE
        • Ghali WA.
        Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data.
        Med Care. 2005; 43: 1130-1139
        • da Silva AR
        SURVEYGENMOD macro: an alternative to deal with complex survey design for the GENMOD procedure.
        SAS Global Forum, Cary, North Carolina2017
        • Otto CM
        • Nishimura RA
        • Bonow RO
        • Carabello BA
        • Erwin JP
        • Gentile F
        • Jneid H
        • Krieger EV
        • Mack M
        • McLeod C
        • O'Gara PT
        • Rigolin VH
        • Sundt TM
        • Thompson A
        • Toly C
        2020 ACC/AHA Guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines.
        Circulation. 2021; 143: e72-e227
        • Movahed MR
        • Ahmadi-Kashani M
        • Kasravi B
        • Saito Y.
        Increased prevalence of mitral stenosis in women.
        J Am Soc Echocardiogr. 2006; 19: 911-913
        • Fleury MA
        • Clavel MA.
        Sex and race differences in the pathophysiology, diagnosis, treatment, and outcomes of valvular heart diseases.
        Can J Cardiol. 2021; 37: 980-991
        • Hung JS
        • Lau KW
        • Lo PH
        • Chern MS
        • Wu JJ.
        Complications of Inoue balloon mitral commissurotomy: impact of operator experience and evolving technique.
        Am Heart J. 1999; 138: 114-121
        • Wunderlich NC
        • Dalvi B
        • Ho SY
        • Küx H
        • Siegel RJ.
        Rheumatic mitral valve stenosis: diagnosis and treatment options.
        Curr Cardiol Rep. 2019; 21: 14
        • Atanda AC
        • Olafiranye O.
        Contrast-induced acute kidney injury in interventional cardiology: emerging evidence and unifying mechanisms of protection by remote ischemic conditioning.
        Cardiovasc Revasc Med. 2017; 18: 549-553
        • Nohria A
        • Hasselblad V
        • Stebbins A
        • Pauly DF
        • Fonarow GC
        • Shah M
        • Yancy CW
        • Califf RM
        • Stevenson LW
        • Hill JA.
        Cardiorenal interactions: insights from the ESCAPE trial.
        J Am Coll Cardiol. 2008; 51: 1268-1274